AR036898A1 - Derivados de hidroxialquilo indolocarbazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents
Derivados de hidroxialquilo indolocarbazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienenInfo
- Publication number
- AR036898A1 AR036898A1 ARP020103953A ARP020103953A AR036898A1 AR 036898 A1 AR036898 A1 AR 036898A1 AR P020103953 A ARP020103953 A AR P020103953A AR P020103953 A ARP020103953 A AR P020103953A AR 036898 A1 AR036898 A1 AR 036898A1
- Authority
- AR
- Argentina
- Prior art keywords
- represent
- indolocarbazol
- hydroxialquilo
- derivatives
- pharmaceutical compositions
- Prior art date
Links
- VVVPGLRKXQSQSZ-UHFFFAOYSA-N indolo[3,2-c]carbazole Chemical compound C1=CC=CC2=NC3=C4C5=CC=CC=C5N=C4C=CC3=C21 VVVPGLRKXQSQSZ-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 108010001483 Glycogen Synthase Proteins 0.000 abstract 1
- 102000002254 Glycogen Synthase Kinase 3 Human genes 0.000 abstract 1
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004990 dihydroxyalkyl group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compuesto de fórmula (1), en la cual: R1 y R2, representan cada uno un grupo elegido entre hidrógeno, alquilo, arilalquilo, hidroxi, hidroxialquilo, dihidroxialquilo, alcoxi, alcoxialquilo, amino y aminoalquilo (eventualmente sustituidos); Ra y Rb, representan cada uno, una cadena alquileno; X1, X2 y X3, representan cada uno, un grupo elegido entre hidroxi, alcoxi, ariloxi, arilalcoxi, alquilo, amino (eventualmente sustituido, halógeno, alquilcarboniloxi y azido; X4, representa un grupo metilideno o un grupo de fórmula -RcX1 tal como se ha definido en la descripción; sus isómeros así como sus sales de adición con un ácido o con una base farmacéuticamente aceptable. Medicamentos útiles como inhibidores de la glicógeno sintetasa quinasa GSK-3.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0113576A FR2831169B1 (fr) | 2001-10-22 | 2001-10-22 | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036898A1 true AR036898A1 (es) | 2004-10-13 |
Family
ID=8868539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103953A AR036898A1 (es) | 2001-10-22 | 2002-10-21 | Derivados de hidroxialquilo indolocarbazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040242508A1 (es) |
| EP (1) | EP1438320A1 (es) |
| JP (1) | JP2005509641A (es) |
| KR (1) | KR100588222B1 (es) |
| CN (1) | CN1253463C (es) |
| AR (1) | AR036898A1 (es) |
| BR (1) | BR0213403A (es) |
| CA (1) | CA2463923A1 (es) |
| EA (1) | EA006201B1 (es) |
| FR (1) | FR2831169B1 (es) |
| HU (1) | HUP0401885A2 (es) |
| MX (1) | MXPA04003741A (es) |
| NO (1) | NO20041761L (es) |
| NZ (1) | NZ532365A (es) |
| PL (1) | PL368237A1 (es) |
| WO (1) | WO2003035663A1 (es) |
| ZA (1) | ZA200402626B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法 |
| WO2008109591A1 (en) * | 2007-03-08 | 2008-09-12 | Lexicon Pharmaceuticals, Inc. | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| RS65632B1 (sr) | 2013-06-05 | 2024-07-31 | Bausch Health Ireland Ltd | Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe |
| CN104031052B (zh) * | 2014-05-20 | 2016-06-08 | 中国科学院南海海洋研究所 | 抗生素Indimicins A–E及其制备方法和在制备抗肿瘤药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4485400A (en) * | 1999-04-26 | 2000-11-10 | Advanced Life Sciences Inc. | Synthetic indolocarbazole regioisomers and uses thereof |
| US6703373B1 (en) * | 1999-09-10 | 2004-03-09 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazole derivatives and antitumor agents |
| FR2801054B1 (fr) * | 1999-11-17 | 2003-06-13 | Adir | Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2001
- 2001-10-22 FR FR0113576A patent/FR2831169B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-21 WO PCT/FR2002/003592 patent/WO2003035663A1/fr not_active Ceased
- 2002-10-21 BR BR0213403-9A patent/BR0213403A/pt not_active IP Right Cessation
- 2002-10-21 AR ARP020103953A patent/AR036898A1/es unknown
- 2002-10-21 HU HU0401885A patent/HUP0401885A2/hu unknown
- 2002-10-21 CA CA002463923A patent/CA2463923A1/fr not_active Abandoned
- 2002-10-21 PL PL02368237A patent/PL368237A1/xx not_active Application Discontinuation
- 2002-10-21 NZ NZ532365A patent/NZ532365A/en unknown
- 2002-10-21 MX MXPA04003741A patent/MXPA04003741A/es not_active Application Discontinuation
- 2002-10-21 EA EA200400533A patent/EA006201B1/ru unknown
- 2002-10-21 EP EP02796813A patent/EP1438320A1/fr not_active Withdrawn
- 2002-10-21 JP JP2003538176A patent/JP2005509641A/ja not_active Ceased
- 2002-10-21 US US10/492,876 patent/US20040242508A1/en not_active Abandoned
- 2002-10-21 KR KR1020047005995A patent/KR100588222B1/ko not_active Expired - Fee Related
- 2002-10-21 CN CNB02820784XA patent/CN1253463C/zh not_active Expired - Fee Related
-
2004
- 2004-04-02 ZA ZA2004/02626A patent/ZA200402626B/en unknown
- 2004-04-29 NO NO20041761A patent/NO20041761L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1253463C (zh) | 2006-04-26 |
| JP2005509641A (ja) | 2005-04-14 |
| MXPA04003741A (es) | 2004-07-23 |
| HK1072774A1 (en) | 2005-09-09 |
| FR2831169B1 (fr) | 2003-12-12 |
| EP1438320A1 (fr) | 2004-07-21 |
| PL368237A1 (en) | 2005-03-21 |
| FR2831169A1 (fr) | 2003-04-25 |
| US20040242508A1 (en) | 2004-12-02 |
| CN1571793A (zh) | 2005-01-26 |
| KR20040054735A (ko) | 2004-06-25 |
| BR0213403A (pt) | 2004-11-03 |
| NZ532365A (en) | 2005-07-29 |
| EA200400533A1 (ru) | 2004-08-26 |
| EA006201B1 (ru) | 2005-10-27 |
| NO20041761L (no) | 2004-04-29 |
| KR100588222B1 (ko) | 2006-06-12 |
| CA2463923A1 (fr) | 2003-05-01 |
| HUP0401885A2 (hu) | 2004-12-28 |
| ZA200402626B (en) | 2005-06-29 |
| WO2003035663A1 (fr) | 2003-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5640136A2 (es) | Derivados de hexahidropiridoisoquinolinas inhibidores de dpp-iv y composiciones farmaceuticas que los contienen | |
| AR033735A1 (es) | Compuestos de alfa-aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| DE60225671D1 (de) | Pharmazeutisch wirksame piperidinderivate | |
| AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| NO20024891L (no) | Farmasöytiske sammensetninger | |
| NO20035524D0 (no) | 4'-substituerte nukleosider | |
| DK1483265T3 (da) | Purinderivater som kinaseinhibitorer | |
| ES2571779T3 (es) | Inhibidores de cinasa a base de nicotinamida | |
| ES2190396T3 (es) | Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| MXPA03010207A (es) | Nuevas 4-anilinoquinolin-3-carboxamidas. | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| PA8548701A1 (es) | Azaindoles | |
| ECSP034896A (es) | Derivados aromaticos de acidos dicarboxilicos | |
| DK1506185T3 (da) | Forbindelser og deres anvendelse som 5-HT-inhibitorer | |
| BR0208741A (pt) | Derivados de piperidina | |
| PA8495101A1 (es) | Derivados de 13-metileritromicina | |
| UY27716A1 (es) | Derivados de nitrosodifenilamina y composiciones farmacéuticas que los comprenden como medicamentos que se pueden utilizar en el tratamiento de patologías que se caracterizan por estrés oxidativo. | |
| SV2004001555A (es) | Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos | |
| GB0308201D0 (en) | Novel compounds | |
| PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
| AR027335A1 (es) | Compuestos de piperidina-4-sulfonamida, proceso de preparacion de los mismos, y composiciones farmaceuticas que los contienen | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| AR036898A1 (es) | Derivados de hidroxialquilo indolocarbazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| IL173810A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| AR035110A1 (es) | Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |